Scilex Holding (SCLXW) Return on Invested Capital (2022 - 2025)
Scilex Holding (SCLXW) recorded quarterly Return on Invested Capital of 0.03% in Q4 2025, up 74.88% quarter-over-quarter from 0.02% in Q3 2025, and up 2.0% on a YoY basis from 0.03% in Q4 2024.
Scilex Holding (SCLXW) Return on Invested Capital (2022 - 2025) Analysis & Trends
Scilex Holding's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.03% for Q4 2025.
- In Q4 2025, Return on Invested Capital rose 2.0% year-over-year to 0.03%; the TTM figure through Dec 2025 stood at 0.03% (up 2.0% YoY), while the FY2025 annual figure was 0.02%, up 2.0% from the prior year.
- Return on Invested Capital was 0.03% for Q4 2025 at Scilex Holding, up from 0.02% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.1% in Q3 2023 to a low of 0.04% in Q2 2023.
- Historically, Return on Invested Capital has averaged 0.01% across 4 years, with a median of 0.01% in 2024.
- Biggest YoY gain for Return on Invested Capital was 5 bps in 2024; the steepest drop was 10 bps in 2024.
- A 4-year view of Return on Invested Capital shows it stood at 0.01% in 2022, then jumped by 259 bps to 0.02% in 2023, then slumped by 69 bps to 0.01% in 2024, then soared by 361 bps to 0.03% in 2025.
- The last three Return on Invested Capital figures came in at 0.03% (Q4 2025), 0.02% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.00% |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 0.00% |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.00% |
| 10 | Scilex Holding | - | - | 4.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03% |
| Sep 30, 2025 | 0.02% |
| Jun 30, 2025 | 0.01% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 0.01% |
| Dec 31, 2023 | 0.02% |
| Sep 30, 2023 | 0.10% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | 0.01% |